Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiperspirant Duration Claim Restrictions Contested By CTFA

This article was originally published in The Tan Sheet

Executive Summary

Restricting enhanced duration claims under the OTC Antiperspirant Drug Products Final Monograph violates First Amendment principles and is inconsistent with FDA regulatory precedent, according to the Cosmetic, Toiletry & Fragrance Association

You may also be interested in...



Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark

Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company

Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark

Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company

Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark

Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company

Topics

UsernamePublicRestriction

Register

LL1132098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel